SVS VQI TransCarotid Revascularization Surveillance Project
VQI-TCAR
TransCarotid Revascularization Surveillance Project of the Society for Vascular Surgery Vascular Quality Initiative
1 other identifier
observational
60,000
1 country
1
Brief Summary
The VQI TCAR Surveillance Project is designed to monitor the safety and effectiveness of stents placed directly into the carotid artery while reversing blood flow within the carotid artery to reduce stroke risk. It will compare this less-invasive surgical procedure with standard carotid endarterectomy in centers that participate in the Society for Vascular Surgery Vascular Quality Initiative.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2016
CompletedFirst Posted
Study publicly available on registry
August 1, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
October 7, 2022
October 1, 2022
10.2 years
July 22, 2016
October 5, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
One-year ipsilateral stroke or death
Any death or stroke in the territory of the treated carotid artery within one year of the carotid artery treatment
1 year
Secondary Outcomes (2)
30-day Stroke or death
30 days
30-day Stroke, death or myocardial infarction
30 days
Study Arms (2)
TCAR treatment
All patients, both high risk and standard risk surgical patients undergoing transcarotid revascularization with a carotid stent during carotid artery flow reversal in hospitals that participate in the Carotid Artery Stent Registry of the Society for Vascular Surgery Patient Safety Organization
CEA treatment
All patients undergoing carotid endarterectomy in hospitals that participate in the Carotid Endarterectomy Registry of the Society for Vascular Surgery Patient Safety Organization
Interventions
Direct implantation of a stent into the carotid artery via a surgical incision in the neck combined with blood flow reversal in the carotid artery during stent placement
Removal of carotid atherosclerotic plaque (endarterectomy) via a surgical incision in the neck
Eligibility Criteria
All patients who undergo TCAR and CEA in hospitals participating in the CAS or CEA registries of the SVS PSO
You may qualify if:
- All patients undergoing TCAR or CEA both standard surgical risk and high surgical risk as defined by the CMS criteria published in the National Coverage Determination for Percutaneous Transluminal Angioplasty (20.7).
You may not qualify if:
- Patients who have received a previous stent in the target artery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Society for Vascular Surgery Patient Safety Organization
Chicago, Illinois, 60611, United States
Related Publications (2)
Schermerhorn ML, Fokkema M, Goodney P, Dillavou ED, Jim J, Kenwood CT, Siami FS, White RA; SVS Outcomes Committee. The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. J Vasc Surg. 2013 May;57(5):1318-24. doi: 10.1016/j.jvs.2012.10.107. Epub 2013 Feb 11.
PMID: 23406712BACKGROUNDKwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, Macdonald S, Cambria RP. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal. J Vasc Surg. 2015 Nov;62(5):1227-34. doi: 10.1016/j.jvs.2015.04.460.
PMID: 26506270BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marc L Schermerhorn, MD
Society for Vascular Surgery Patient Safety Organization
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2016
First Posted
August 1, 2016
Study Start
November 1, 2016
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
October 7, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share